Td Waterhouse Canada Inc. Moderna, Inc. Transaction History

Td Waterhouse Canada Inc.

$12.3 Trillion
Q3 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 3,080 shares of MRNA stock, worth $121,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,080

Previous 6,102 49.52%

Holding current value

$121,321

Previous $707 Million 72.18%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$63.64 - $125.14 $192,320 - $378,173	-3,022 Reduced 49.52%	3,080 $197 Million
Q2 2024 Nov 12, 2024	SELL	$101.21 - $166.61 $43,520 - $71,642	-430 Reduced 6.58%	6,102 $707 Million
Q2 2024 Aug 02, 2024	BUY	$101.21 - $166.61 $16,193 - $26,657	160 Added 2.51%	6,532 $904 Million
Q1 2024 May 10, 2024	BUY	$85.37 - $115.44 $48,319 - $65,339	566 Added 9.75%	6,372 $683 Million
Q4 2023 Feb 12, 2024	SELL	$69.51 - $104.43 $51,089 - $76,756	-735 Reduced 11.24%	5,806 $647 Million
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $38,756 - $50,897	402 Added 6.55%	6,541 $696 Million
Q2 2023 Nov 13, 2023	BUY	$118.5 - $160.53 $103,687 - $140,463	875 Added 16.62%	6,139 $765 Million
Q1 2023 Nov 13, 2023	SELL	$135.66 - $197.02 $11,666 - $16,943	-86 Reduced 1.61%	5,264 $869 Million
Q4 2022 Nov 13, 2023	SELL	$118.38 - $210.04 $85,115 - $151,018	-719 Reduced 11.85%	5,350 $983 Million
Q3 2022 Nov 13, 2023	SELL	$118.07 - $194.18 $23,495 - $38,641	-199 Reduced 3.17%	6,069 $752 Million
Q2 2022 Nov 13, 2023	SELL	$117.13 - $176.59 $90,307 - $136,150	-771 Reduced 10.95%	6,268 $979 Million
Q1 2022 Nov 13, 2023	SELL	$126.46 - $235.05 $22,256 - $41,368	-176 Reduced 2.44%	7,039 $1.28 Billion
Q4 2021 Nov 13, 2023	BUY	$225.82 - $368.51 $1.63 Million - $2.66 Million	7,215 New	7,215 $1.74 Billion

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account

Td Waterhouse Canada Inc. Moderna, Inc. Transaction History